A i n u o f studv: Investigation o f the pharmacokinetics and pharmncodynanllcs o f huprenorphine i n the preterm newborn. This has not been studied previously.
Cnnclusinns ( I ) Buprcnorphinc illfusion i n tllis ;Ige gro111, slloucd ir~crc;lscd stc.ldy slate concentration, reduced clearance artd prolonged h a l f -l~f c cu111~1arcc1 to older childrcn and adults. (2) Bttprcnorph~nc in thc prc-term ncwborn ;lppcars to bc saic hut no1 always effeclive. (3) There is a non-standard rclatior~ship hcla.ccn the pharrn;lcological effect ancl plasma drug con cent ratio^^ which rnakcs I~u p r e n u r~~h~r~c inappropriate for use in neonalal intensive care.
NATURAL SURFACTANT (SF) VS. BRIEF L I Q U I D VENTILATION ( L V ) RESCUE THERAPY I N VERY IMMATURE LAMBS.
A d o l f V a l l s -1 -S o l e r * , M a r l a W o l f s o n , Thomas S h a f f e r . s p n . b y J u a n R S o r i a n o * .
T e m p l e U n i v e r . D e~t . P h v s i o l -P e d i a t . P h i l a d e lp h i a USA a n d f * ) D e~t . P e d i a t : ~a s u i e U n i v e r . Bilbao~soain. r -r --. . .
-I n i m m a t u r e i a m b s p r o h lac tic'^^ p r o v i d e s --b i t f e r g a s
e x c h a n e t h a n g a s v e n t i y a z i o n (GV). I n 2 g r o u p s o f a g em a t c h e l l a m b s ( g e s t -l l l + l d ) , a f t e r GV f o r f i r s t 4 5 m l n o f l i f e , l a m b s w e r e r e s c u e a : G -I ( n -6 ) a n d GV (G-1V:n-9) s i n c e b i r t h (J.App1. P h y s i o l . 7 2 : 1 0 2 4 : 1 9 9 2 ) . O x y g e n a t i o n i m p r o v e d a f t e r t h e r a p y i n b o t h r e s c u e g r o u p s , n o t r e a c h i n g G -I 1 1 l e v e l s . I n G -I 1 p a 0 2 d e c r e a s e b y 2.5h, a n d i n G -I r e m a i n e d u n c h a n g e d w h i l e P I P a n d PEEP b o t h G -I a n d I 1 p u l m o n a r y c o m p l i a n c e s i m i l a r l y i n c r e a s e d a f t e r r e s c u r e a n d c o m p a r e d t o u n t r e a t e d l a m b s b e e n l e s s t h a n i n G-111. L a b e l e d SF was d i s t r i b u t e d w i i h > 6 5 % o f l u n g s e c t i o n s w i t h a n a m o u n t w i t h i n 2 0 % o f mean. leed ding t h r o u g h t r a c h e a l t u b e was s e e n i n 5 / 8 l a m b s i n C -I i m m e d ia t e l y a f t e r t r e a t m e n t a n d was n o t s e e n i n o t h e r g r o u p s . G r o s s a n d m i c r o s c o p i c e x a m i n a t i o n o f l u n g s d e m o n s t r a t e d e v i d e n c e o f hemmorhage a n d u n e v e n i n f l a t i o n i n a l l g r o u p s b u t C-111. E v e n i n v e r y i m m a t u r e l a m b s b o t h r e s c u e s t r a t e g i e s t r a n s i e n t l y i m p r o v e g a s e r c h a n a n d p u l m o n a r y f u n c t i o n : a l t h o u g h e x p o s u r e o f i m m a t u r e T u n g t o GV a f t c r ) has bccn corrclntcd w l t l~ pcrslstcnt surluctur~t dcfic~crlcy, i~ l~r o l o~~g~~d ncutrophll influx and a dccrcascd macrophage response In trnchcai asplratc contents during the second h a l l of the first week. These variablca have nut been studied comparing mild (type I ) and severe (type 2) forms of Ut'L). \Ye prospcctlvcly trlcnsurcd SI'-A, l~r o t c l n c n~i c r r l t r a t i~~n , ncutr~,lll~tl :~r~< l rrl;t<-r<r-phage counts In 376 trachcal aspirate sarnples o f 105 cor~sccut~vcly v c n t~l atcd newborn infants In a longitudinal fashlon. F~l t y -e i g h t patients had RDS (group A). 28 had pulmonary d~scnses other than RDS (groull I j ) ur10 19 had no lung disease (group C). A t day I, RDS patients had lowcr levels o f SP-A, protein, ncutrophll and macrophnge counts than Infants o f groups B and C. Among patients wlth RDS, survival without UI'D was associated wlth an increase I n tracheal SP-A concentration, neutrophil and macrophage count bctwcen day I and day 3 t o 5; type I UI'D was assoclatcd w l~l~ on lncrcase 111 SP-A w i t l~u u t o ccllulur III~I~IX, und 'puor IIIIL~:OI~I~' (type 2 111' 1) or IIOII- survival at day 28) was assoclatcd wlth neither SP-A lncrcasc nor lnllammatory response. Our findings conftrm that a sustained Increase In trachcal surfactant conccntrutlon and rnucropl~ogc courll Is uvsuclutcd wit11 III>S survival wlthout UPD. However, contrary t o current understanding, i t is suggested that cure o f RDS also requires a neutrophil inflammatory response, which Is absent I n type 1 and type 2 UPD patients and nonsurvivors. The latter two also f a l l to produce surlactant. Early treatrncnt with corticosteroids may therefore not be appropriate for thcsc infants. U.lqlum and ~~C~u n l n q o~~, Tho N u~l~e r l a n d u .
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Indomethacine ( I n d o ) i s convnonly used f o r treatment o f FDA, i t s main aide a f f e c t i s r e n a l f a i l u r e .
A s p i r i n (Ash) Is a n a l t e r n a t i v e b u t t h e r e are no c o n t r o l l e d t r i a l s on i t s e f f i c a c y . W e randomly as~i g n e d 75 premature i n f a n t s s u f f e r i n g from RDS (mean GA: 29.6 t 2.5 wks, mean BW: 1295 i 464 g r ) on a r t i f i c i a l v e n t i l a t i o n a t s t a r t o f study (mean : 3.4 day o f l i f e ) , t o e l t h s r Indo (3 x 0.2 m g l k g j l 2 h r e ) o r ASA (4 x 15 mg/kg/6 h r s ) .
POP. and degree o f shunting were diaqnosed by echocardlo-Doppler a t s t a r t and a f t e r 2 and 4 days. Side e f f e c t s , e e p e c l a l l y d l m i n u t l o n of d l u r e e i s , were c a r e f u l l y recorded.
ResultetPDA cloead i n 35/38 p a t i e n t 8 from the Indo group (93 \ ) and i n 16/37 patient. from the ASA group (43 \ ) (p<0.001).
No reop e n l n g s were obmerved I n b o t h groups. 19 p a t i e n t s needed f u r t h e r treatment w i t h Indo o r murgery (17 I n the ASA group and 2 i n t h e Indo g r o u p ) . No s i d e e f f e c t s were seen i n b o t h groups except f o r a dec r e a s e o f d l u r e s l s i n t h e Indogroup d u r i n g 4 p o s t t r e a t m e n t days l d i f f e r e n c e on 2nd p o s t t r e a t m e n t day: Indo minus 1.06 m l / k g / h v s ASAI p l u s 0.48 m l / k g / h i p<0.01). and dcsalura~cd (IIB-) In 24 rats Thc rats ucrc dltldcd tnlo 2 groups (Gp) Gpl (12). Wt=2n6+lng (nliSD) rcccl\cl: A1 (dor 200 mgkg IP) and was subjcctcd lo I12 hr pcr~od o l 9 7%02 lolloucd bj I(H)"&, Gg2 (12). Wl-282?JIg (miSD) war subjcctcd lo Ihc sanlc 2 pcrtods olF102 bul ut~hout prior Al *Rrsultr: GIII W~th admln~slral~on of 9 7% 02. C ) m j h a m e morc rcduccd, b) as much as ! MI : ; ol told1 l~bllc slgnal CTLS). UIIII conconlltatlt 1, 111 111 U'/ and 11bO and rnr on Ilb-W~llt ~dt~~tr8~rlraltor or 100% 02. C)taa3 bccanlc nlorc o\ld~/crl \\ltll co!!comllanl r t r la BV and llbO and LII 11, Ilb-G1, 2 Dur~ng Ihc h)po\lc pcrlod (') lhc clungcs In C)laa3. BV, llbO and Ilb-ucrc slnlllar lo thor oblalncd In Gpl Howcvcr on rco\)gc~latlon allll 100% 02 Ihc C)laal rcrnaaacd rcduccd dcsptlc lncrcascs In BV and HbO and lall In Ilb-To c\alualc Ihc rolc o l IIS and XO ~n thcr changcs.all addltlonal 6 rats on 100% O2 ucrc lnluscd ullh I HX (dor cnlcul;llcd lo protldc ;I plasma conccnlrallon 30 pWdl) 2 IIX allh Arab~nor (dor 2-4 nll o l 1 6 M Sol ) 3 llX + SO ( I unt~) lnlus~on of ILX, and XO. wlth or unhout arablnor, dld not rcsull In an! chrl~gc ~n C!I.LI] Our rcsuils suggcst lhal allopur~nol prolcct lhc n~tlcchondrlal clcctron-lrasrpan clt.xln front 0; dijrlng rco\)gcnal~on-rcpcrlus~on lolloa~ng ccrcbral It)po~~c-~scl~cn~~c 11yur) pr&.tbl! b! rc:l\cl\itng 0!. r:lll~cr 11 ,I b) lnhlbltlon o l %anll~~nc o\ldasc 
